<DOC>
	<DOC>NCT01663350</DOC>
	<brief_summary>This is a prospective, multi‐center observational study designed to compare the test results of the Verinata Health Prenatal Aneuploidy Test to results of conventional prenatal screening for fetal chromosome abnormalities in 'all-risk' pregnancies.</brief_summary>
	<brief_title>Comparison of Aneuploidy Risk Evaluations</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Down Syndrome</mesh_term>
	<mesh_term>Aneuploidy</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<criteria>Age 18 years or older at enrollment Clinically confirmed pregnancy Gestational age ≥8 weeks, 0 days Planned or completed prenatal serum screening* (drawn during 1st and/or 2nd trimester) Pregnancy records accessible and available for data collection (e.g., results from screening, ultrasound examinations, invasive prenatal procedures if performed, and newborn hospital discharge exam) Able to provide consent for participation using language appropriate forms Invasive prenatal procedure (amniocentesis or CVS) performed within 2 weeks prior to enrollment Prenatal screening determination by Nuchal Translucency (NT) measurement only</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>